Cancer Early Manufacturers, Suppliers & Companies
-
Manufacturerbased in Menlo Park, CALIFORNIA (USA)
We are a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power ...
Grail Galleri - Multi-cancer Early Detection Test Kit
The earlier that cancer can be found, the higher the chance of successful treatment and survival. Yet, too often cancer goes undetected until it has progressed to an advanced ...
CONTACT SUPPLIER -
Technologybased in New York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
Technology for Early Cancer Detection
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per year over the ...
CONTACT SUPPLIER -
Manufacturerbased in Guro-gu, SOUTH KOREA
We provide diagnostic solutions throughout the cancer treatment cycle from early cancer diagnosis to prognostic and companion diagnostics as well as postoperative monitoring. Diagnose cancer as early as possible, when the disease is easiest to ...
Model eDX - Early Diagnosis for Cancer With Liquid Biopsy
What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal ...
CONTACT SUPPLIER -
Manufacturerbased in Bristol, UNITED KINGDOM
Micrima have developed MARIA®, a radiowave breast detection tool, initially pioneered at the University of Bristol in the UK. Micrima are transforming the detection of breast cancer for all women, making a difference to the early diagnosis of breast ...
MARIA - Breast Cancer Detection Tool
Micrima are aiming to open up breast screening to all women. With breast cancer being the most common cancer in women of all ages globally, we believe that all women should be able to have breast screening. The ...
CONTACT SUPPLIER -
Technologybased in San Diego, CALIFORNIA (USA)
We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19. Cancer is genetically diverse, highly adaptive, constantly mutating and virtually invisible to ...
Model VIREX - Next-generation at-home Dx Testing with PCR-level Sensitivity for Daily Covid-19 Tests and Early Cancer Dx
Demonstrated extremely high sensitivity for multiple biological analytes, including: COVID-19 virus detection as sensitive as 5 TCID50, rivalling PCR sensitivity, Early liver cancer biomarker test detects target ...
CONTACT SUPPLIER -
Technologybased in Phoenix, ARIZONA (USA)
VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...
Model LuCED Test - Lung Cell Evaluation Device
The LuCED test is a non-intrusive sputum sample that we collect from you and then analyze using our Cell-CT machine. From this sample, LuCED is designed to detect lung cancer early by detecting the abnormal cells. ...
CONTACT SUPPLIER -
Manufacturerbased in Cleveland, OHIO (USA)
Cleveland Diagnostics, Inc. is a commercial-stage diagnostics company developing highly efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. The Company’s Solvent Interaction Analysis ...
IsoPSA - Prostate Biopsy Testing System
IsoPSA Proceed to biopsy only when needed. IsoPSA is now included in NCCN® Prostate Cancer Early Detection Guidelines. IsoPSA can help reduce unnecessary prostate biopsies by up to 55%. Up to 75% of results from ...
CONTACT SUPPLIER -
Manufacturerbased in Seville, SPAIN
We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...
-
Manufacturerbased in Isfiya, ISRAEL
At Check-Cap our experienced and motivated team is committed to increasing screening adherence and helping to reduce the global incidence of colorectal cancer (CRC) through cancer prevention. Our patented technology C-Scan is the first and only ...
-
Service providerbased in Guangzhou, CHINA
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy ...
-
Manufacturerbased in Amsterdam, NETHERLANDS
Self-screen has a long history and track record in translational HPV related science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of HPV related cancer screening into routine practice. Our ...
Development Services
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. This could be in ...
CONTACT SUPPLIER -
Technologybased in Salt Lake City, UTAH (USA)
IONIQ Sciences’ vision is to dramatically improve the cancer landscape with a modern solution at the point-of-care for early detection of multiple cancers thereby expanding the therapeutic window, significantly improving survivability, and reducing ...
-
Manufacturerbased in Buford, GEORGIA (US) (USA)
Continuing To Do More To Save More Lives. Theragenics was founded in 1981 and quickly became a global leader in the manufacture of radioactive brachytherapy seeds for the treatment of localized prostate cancer. We began diversifying operations in ...
-
Manufacturerbased in Guildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
Cancertrack - Model 360 - Cancer Treatments Technology
Cancertrack is an advanced non-invasive blood test which provides real time intel on the status of a malignancy from a safe, simple and quick blood draw. Cancertrack profiles molecular features in circulating tumor DNA and circulating tumor RNA and ...
CONTACT SUPPLIER -
Manufacturerbased in Beverly, MASSACHUSETTS (USA)
Cellanyx is a growth stage emerging biotech advancing proprietary phenotypic (appearance and dynamics) biomarker tests based on Machine Vision and AI-driven analysis of live single tumor cells to improve risk-stratification and shared clinical ...
Cellanyx - Breast Cancer LDT Test
Risk stratification of early-stage breast cancer is an active area of research and several commercially available products that are based on genotypic classification. A vexing issue in breast cancer ...
CONTACT SUPPLIER -
Service providerbased in Nottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Early Detection of Lung Cancer
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood ...
CONTACT SUPPLIER -
Software vendorbased in Waltham, MASSACHUSETTS (USA)
Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have helped biotech and pharmaceutical companies ...
-
Manufacturerbased in Louisville, KENTUCKY (USA)
Breath Diagnostics, Inc. (“Breath-Dx” or “the Company”), is a medical-device diagnostics company developing a novel, patented breath analysis system to quantify cancer specific markers in exhaled breath. The Company’s proprietary technology, ...
OneBreath Technology
method for lung cancer detection/diagnosis to date. The OneBreath™ test can be done in office-based, and retail (pharmacy/drugstores) settings, enabling greater accessibility to lung cancer screening and ...
CONTACT SUPPLIER -
Technologybased in Jena, GERMANY
As a biotechnology company, we at oncgnostics GmbH have been working on the diagnosis of cancer on a molecular biological basis since 2012. Our cancer tests are used in early cancer detection and diagnosis.Our first product, GynTect®, was developed ...
-
Manufacturerbased in Richmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
BioMark - Model SSAT1 - Diagnostics Liquid Biopsy Assay
alert tool, it is valuable to physicians around the world. It is a valuable tool for early stage cancer ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you